The researchers found that the proportion of patients achieving target BP was increased with the triple combination pill versus usual care at 6 months (70 vs 55%; risk difference, 12.7%). HealthDay ...
NEW YORK—An investigational triple regimen of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) may result in significantly greater mean reductions in BP compared ...
Hypertension is a serious public health concern worldwide, and due to population growth and ageing, the number of people with uncontrolled hypertension continues to rise. Data from the National Health ...
Blood pressure gauge, hypertension Proportion achieving target BP increased with use of triple combo pill vs usual care at 6 months. HealthDay News — Treatment with a pill combining low doses of three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results